Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
150 GBX | 0.00% | +17.65% | -50.82% |
May. 03 | Kelso raises stake in NCC; Transense joins project | AN |
Apr. 30 | Faron Pharmaceuticals Ltd. Announces Appointment of Dr. Juho Jalkanen as Director | CI |
Sales 2024 * | 14.4M 15.5M | Sales 2025 * | 39.09M 42.07M | Capitalization | 126M 135M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.46M | Net income 2025 * | -4M -4.3M | EV / Sales 2024 * | 10.9 x |
Net Debt 2024 * | 30.6M 32.93M | Net cash position 2025 * | 42.27M 45.48M | EV / Sales 2025 * | 2.14 x |
P/E ratio 2024 * |
-5.7
x | P/E ratio 2025 * |
-11.3
x | Employees | 34 |
Yield 2024 * |
0.86% | Yield 2025 * |
-
| Free-Float | 60.17% |
Latest transcript on Faron Pharmaceuticals Oy
1 week | +17.65% | ||
Current month | +3.45% | ||
3 months | -47.74% | ||
6 months | -41.18% | ||
Current year | -50.82% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 02-12-31 | |
Founder | 46 | 02-12-31 | |
Founder | 70 | 02-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 70 | 02-12-31 | |
Chairman | 60 | 23-03-23 | |
Founder | 46 | 02-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 150 | 0.00% | 8,165 |
24-05-02 | 150 | 0.00% | 4,213 |
24-05-01 | 150 | +3.45% | 1,565 |
24-04-30 | 145 | +3.57% | 21,598 |
24-04-29 | 140 | +9.80% | 23,594 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.82% | 136M | |
-1.43% | 104B | |
+8.96% | 105B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- FARN Stock